Even so, the absence of AQP4‐IgG leaves the clinician with the possibility of an alternative diagnosis, such as an optic‐spinal form of MS or another IDD of the CNS (Juryńczyk et al., 2016; Weinshenker & Wingerchuk, 2017). Here, AQP4 is linked to myeloid sarcoma.